Adial Pharmaceuticals Valuation
| ADIL Stock | USD 0.46 0.01 3.18% |
Adial Pharmaceuticals is undervalued. Adial Pharmaceuticals shows a prevailing Real Value of $1.98 per share. The current price of the firm is $0.4643. Our model approximates the value of Adial Pharmaceuticals from analyzing the firm fundamentals such as Current Valuation of 4.75 M, shares owned by insiders of 3.41 %, and Return On Equity of -2.17 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Adial Pharmaceuticals' valuation include:
Undervalued
Today
Please note that Adial Pharmaceuticals' price fluctuation is abnormally volatile at this time. Calculation of the real value of Adial Pharmaceuticals is based on 3 months time horizon. Increasing Adial Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Adial stock is determined by what a typical buyer is willing to pay for full or partial control of Adial Pharmaceuticals. Since Adial Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Adial Stock. However, Adial Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.46 | Real 1.98 | Target 6.5 | Hype 0.5 | Naive 0.49 |
The intrinsic value of Adial Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Adial Pharmaceuticals' stock price.
Estimating the potential upside or downside of Adial Pharmaceuticals helps investors to forecast how Adial stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Adial Pharmaceuticals more accurately as focusing exclusively on Adial Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Adial Pharmaceuticals' intrinsic value based on its ongoing forecasts of Adial Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Adial Pharmaceuticals' closest peers.
Adial Pharmaceuticals Cash |
|
Adial Valuation Trend
Knowing Adial Pharmaceuticals' actual value is paramount for traders when making sound investment determinations. Using both Adial Pharmaceuticals' enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Adial Pharmaceuticals Total Value Analysis
Adial Pharmaceuticals is presently forecasted to have valuation of 4.75 M with market capitalization of 7.12 M, debt of 975.86 K, and cash on hands of 9.16 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Adial Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
4.75 M | 7.12 M | 975.86 K | 9.16 M |
Adial Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Adial is to check how much profit was generated for every dollar of assets it reports. Adial Pharmaceuticals shows a negative utilization of assets of -1.07 percent, losing $0.0107 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Adial Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Adial Pharmaceuticals Ownership Allocation
Adial Pharmaceuticals holds a total of 15.78 Million outstanding shares. Adial Pharmaceuticals shows 3.41 percent of its outstanding shares held by insiders and 3.64 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Adial Pharmaceuticals Profitability Analysis
Net Loss for the year was (13.2 M) with profit before overhead, payroll, taxes, and interest of 0.About Adial Pharmaceuticals Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Adial Pharmaceuticals. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Adial Pharmaceuticals based exclusively on its fundamental and basic technical indicators. By analyzing Adial Pharmaceuticals's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Adial Pharmaceuticals's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Adial Pharmaceuticals. We calculate exposure to Adial Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Adial Pharmaceuticals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | (507.60) | (532.98) |
Adial Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Adial Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 18.6 M |
Adial Pharmaceuticals Current Valuation Indicators
Adial Pharmaceuticals' valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Adial Pharmaceuticals' valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Adial Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Adial Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Adial Pharmaceuticals' worth.When determining whether Adial Pharmaceuticals is a strong investment it is important to analyze Adial Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Adial Pharmaceuticals' future performance. For an informed investment choice regarding Adial Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Adial Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Adial Stock please use our How to buy in Adial Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Adial Pharmaceuticals. If investors know Adial will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Adial Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Adial Pharmaceuticals is measured differently than its book value, which is the value of Adial that is recorded on the company's balance sheet. Investors also form their own opinion of Adial Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Adial Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Adial Pharmaceuticals' market value can be influenced by many factors that don't directly affect Adial Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Adial Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Adial Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Adial Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.